SSE: 002252 - Shanghai RAAS Blood Products Co., Ltd.

Yield per half year: 0%
Dividend yield: +0.39%
Sector: Healthcare

Reporting Shanghai RAAS Blood Products Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
51.03
Выручка, млрд ¥
6.94
Чистая прибыль, млрд ¥
2.05
EV, млрд ¥
46.21
EBITDA, млрд ¥
2.29


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
4.82
Долг, млрд ¥
0.0017


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 0.31


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 7.34 7.85
ROA, % 4.47 4.30
ROS, % 29.54 29.54 29.54 29.54 8.11
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 33 33 -351.29
Чистая рентаб, % 29.53 8.10
Operation Margin, % 0 0 0 0 4.29


Coefficients

IFRS
Reporting Annual Quarterly
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
24.74 36.76
P/BV
1.74 3.67
P/S
7.31 13.01
P/FCF
0 0 0 0 7.85
E/P
0.0402 0.0402 0.0402 0.0402 0.03
EV/EBITDA
18.71 19.30
EV/EBIT
0 0 0
EV/S
6.66 6.66 6.66 6.66 59.91
EV/FCF
0 0 0 4.07
Debt/EBITDA
0.000742 0.000742 0.000742 0.000742 1.91
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.07
Debt/Equity
0 0 0 0 0.14
Debt/Net Income
0.000829 0.000829 0.000829 0.000829 3.99
Бета
0 0 0 0 0.15
Индекс Альтмана
0 0 0 0 7.02


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0.03
Див доход, ао, %
0.39 0.81
Дивиденды / прибыль, %
9.15 41.32


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
3121 3121